In the present study, we demonstrated that inducing PKR in lung cancer cells activates the AMPK protein independent of the LKB1, TAK1, and CaMKKβ pathways by increasing AMP levels and decreasing ATP levels. The gene discussed is MAP3K7; the disease is lung cancer.